Publications

Iman Touati, Mohnad Abdalla, Yassir Boulaamane, Nawal Al-Hoshani, Abdulaziz Alouffi, Mohammed Reda Britel, Amal Maurady (2023). Identification of novel dual acting ligands targeting the adenosine A2A and serotonin 5-HT1A receptors. Journal Article.
PDF DOI
Yassir Boulaamane, Iman Touati, Nainee Goyal, Anshuman Chandra, Lokesh Kori, Mahmoud A. A. Ibrahim, Amal Maurady (2023). Exploring natural products as multi-target-directed drugs for Parkinson’s disease: an in-silico approach integrating QSAR, pharmacophore modeling, and molecular dynamics simulations. Journal Article.
PDF DOI
Yassir Boulaamane, Kailash Jangid, Mohammed Reda Britel, Amal Maurady (2023). Probing the molecular mechanisms of α-synuclein inhibitors unveils promising natural candidates through machine-learning QSAR, pharmacophore modeling, and molecular dynamics simulations. Journal Article.
PDF DOI
Yassir Boulaamane, Pallavi Kandpal, Anshuman Chandra, Mohammed Reda Britel, Amal Maurady (2023). Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE. Journal Article.
PDF DOI
Yassir Boulaamane, Mohammed Reda Britel, Amal Maurady (2023). Insights into the Structure-Activity Relationship of Alkynyl-Coumarinyl Ethers as Selective MAO-B Inhibitors Using Molecular Docking. Book Chapter.
PDF DOI
Suneeta Bhandari, Akansha Agrwal, Virendra Kasana, Shishir Tandon, Yassir Boulaamane, Amal Maurady (2022). β-amino carbonyl derivatives: Synthesis, Molecular Docking, ADMET, Molecular Dynamic and Herbicidal studies. Journal Article.
PDF DOI
Yassir Boulaamane, Mahmoud A. A. Ibrahim, Mohammed Reda Britel, Amal Maurady (2022). In silico studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AA2AR antagonists for the treatment of Parkinson's disease. Journal Article.
PDF DOI
Yassir Boulaamane, Iqrar Ahmad, Harun Patel, Niloy Das, Mohammed Reda Britel, Amal Maurady (2022). Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors. Journal Article.
PDF DOI